🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to users administering products of uncertain source.

Several experts said the popularity for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

According to the social media company, the service has taken down problematic material and banned related hashtags and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.

After moments of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Inside these communities, messages show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to potentially significant medical dangers”.